Alternate splicing of the p53 inhibitor HDMX offers a superior prognostic biomarker than p53 mutation in human cancer.

Alternate splicing of the p53 inhibitor HDMX offers a superior prognostic biomarker than p53 mutation in human cancer.

Conventional high-grade osteosarcoma is the most common primary bone malignancy. Although altered expression of the p53 inhibitor HDMX (Mdmx/Mdm4) is associated with cancer risk, progression, and outcome in other tumor types, little is known about its role in osteosarcoma. High expression of the Hdm...

Podrobná bibliografie
Hlavní autoři:	Lenos, K, Grawenda, A, Lodder, K, Kuijjer, M, Teunisse, A, Repapi, E, Grochola, L, Bartel, F, Hogendoorn, P, Wuerl, P, Taubert, H, Cleton-Jansen, A, Bond, G, Jochemsen, A
Médium:	Journal article
Jazyk:	English
Vydáno:	2012

Podobné jednotky

A RASSF1A polymorphism restricts p53/p73 activation and associates with poor survival and accelerated age of onset of soft tissue sarcoma.
Autor: Yee, K, a další
Vydáno: (2012)

Single-nucleotide polymorphisms in the p53 signaling pathway.
Autor: Grochola, L, a další
Vydáno: (2010)

The identification and analysis of molecular biomarkers in the p53 tumour suppressor pathway that affect cancer progression in humans
Autor: Grawenda, A, a další
Vydáno: (2013)

Proapoptotic p53-interacting protein 53BP2 is induced by UV irradiation but suppressed by p53
Autor: Lopez, C, a další
Vydáno: (2000)

Induction of p53 and up-regulation of the p53 pathway in the human 5q- syndrome.
Autor: Pellagatti, A, a další
Vydáno: (2010)

Rescuing the function of mutant p53.
Autor: Bullock, A, a další
Vydáno: (2001)

Chemosensitivity profiles identify polymorphisms in the p53 network genes 14-3-3tau and CD44 that affect sarcoma incidence and survival.
Autor: Vazquez, A, a další
Vydáno: (2010)

Small-Molecule Reactivation of Mutant p53 to Wild-Type-like p53 through the p53-Hsp40 Regulatory Axis
Autor: Hiraki, Masatsugu, a další
Vydáno: (2017)

Inability of p53-reactivating compounds Nutlin-3 and RITA to overcome p53 resistance in tumor cells deficient for p53Ser46 phosphorylation
Autor: Teng, Ma, a další
Vydáno: (2012)

Tanning, p53 and PCMR.
Autor: Goding, C
Vydáno: (2008)

Nucleophosmin and p14ARF mediated regulation of p53
Autor: Abraham, A
Vydáno: (2015)

A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans.
Autor: Bond, G, a další
Vydáno: (2004)

p53 nuclear localization control, and p53-dependent regulation of DNA repair gene transcripts
Autor: Boyd, Scott D. (Scott Dexter), 1970-
Vydáno: (2006)

Molecular regulation of p53-dependent tumour suppressor responses by the p53 binding protein 1
Autor: Cuella-Martin, R
Vydáno: (2018)

Interaction of the p53 DNA-binding domain with its n-terminal extension modulates the stability of the p53 tetramer.
Autor: Natan, E, a další
Vydáno: (2011)

Lysine methylation and the regulation of p53.
Autor: Carr, S, a další
Vydáno: (2012)

Modelling oligomerization of p53 family.
Autor: Lee, Yin Yeng.
Vydáno: (2010)

Reversible p53 expression in lung cancer.
Autor: Pezzella, F, a další
Vydáno: (1992)

Sequence-dependent sliding kinetics of p53
Autor: Leith, Jason S., a další
Vydáno: (2013)

The imidazoacridinone C-1311 induces p53-dependent senescence or p53-independent apoptosis and sensitizes cancer cells to radiation
Autor: Skwarska, A, a další
Vydáno: (2017)

The genetics of the p53 pathway, apoptosis and cancer therapy.
Autor: Vazquez, A, a další
Vydáno: (2008)

Structural evolution of p53, p63, and p73: implication for heterotetramer formation.
Autor: Joerger, A, a další
Vydáno: (2009)

The importance of p53 pathway genetics in inherited and somatic cancer genomes
Autor: Stracquadanio, G, a další
Vydáno: (2016)

A Large Intergenic Noncoding RNA Induced by p53 Mediates Global Gene Repression in the p53 Response
Autor: Huarte, Maite, a další
Vydáno: (2015)

Imaging p53 in pancreatic ductal adenocarcinoma
Autor: Koustoulidou, S
Vydáno: (2017)

Arginine methylation regulates the p53 response.
Autor: Jansson, M, a další
Vydáno: (2008)

ASPP--Apoptotic specific regulator of p53.
Autor: Liu, Z, a další
Vydáno: (2005)

The role of the p53 protein in the apoptotic response.
Autor: Lane, D, a další
Vydáno: (1994)

p53 methylation--the Arg-ument is clear.
Autor: Durant, S, a další
Vydáno: (2009)

The role of p53 in hypoxia-induced apoptosis
Autor: Poole, R
Vydáno: (2010)

p21WAF1/CIP1 and MDM2 expression in non-Hodgkin's lymphoma and their relationship to p53 status: a p53+, MDM2-, p21-immunophenotype associated with missense p53 mutations.
Autor: Villuendas, R, a další
Vydáno: (1997)

iASPP preferentially binds p53 proline-rich region and modulates apoptotic function of codon 72-polymorphic p53.
Autor: Bergamaschi, D, a další
Vydáno: (2006)

Ultraslow oligomerization equilibria of p53 and its implications.
Autor: Natan, E, a další
Vydáno: (2009)

Defect in serine 46 phosphorylation of p53 contributes to acquisition of p53 resistance in oral squamous cell carcinoma cells
Autor: Arief Ichwan, Solachuddin Jauhari, a další
Vydáno: (2006)

A new strategy to resume the apoptosis activity of p53 in leukemia cell lines retaining wild-type p53
Autor: Liu, Z, a další
Vydáno: (2007)

A new strategy to resume the apoptosis activity of p53 in leukemia cell lines retaining wild-type p53.
Autor: Liu, Z, a další
Vydáno: (2007)

Mutations in the p53 gene are not limited to classic 'hot spots' and are not predictive of p53 protein expression in high-grade non-Hodgkin's lymphoma.
Autor: Kocialkowski, S, a další
Vydáno: (1995)

EXPRESSION OF p53 AND p63 IN CERVICAL SQUAMOUS CELL CARCINOMA
Autor: , ILHAMI ROMUS, a další
Vydáno: (2013)

The role of p53 in the immunobiology of cutaneous squamous cell carcinoma.
Autor: Black, A, a další
Vydáno: (2003)

Cell cycle-dependent nuclear retention of p53 by E2F1 requires phosphorylation of p53 at Ser315.
Autor: Fogal, V, a další
Vydáno: (2005)